This is a notable finding as multiple studies have shown that glucocorticoid treatment in ALL represses C-MYC expression, and glucocorticoid resistance is associated with C-MYC over-expression.22,55–58. This evidence concerns the gene MYC and acute lymphoblastic leukemia.